POLYPEPTIDE LABORATORIES A/S: Financial statements 2022
CVR: 19056201
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
POLYPEPTIDE LABORATORIES A/S (CVR 19056201) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -3,033,000 compared with DKK -839,000 the year before. Equity in the 2022 report amounted to DKK 62,578,000. The solvency ratio was 99.9%.
- Profit/Loss
- DKK -3,033,000
- Equity
- DKK 62,578,000
- Total Assets
- DKK 62,614,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | -3 mio. | 62.6 mio. | - |
| 2021 | - | - | -839 t. | 65.6 mio. | - |
| 2020 | - | 0 | 1.3 mio. | 66.5 mio. | - |
| 2019 | - | 24 t. | -824 t. | 65.2 mio. | - |
| 2018 | - | 0 | -1.5 mio. | 66 mio. | - |
Official annual report
Keep an eye on POLYPEPTIDE LABORATORIES A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
POLYPEPTIDE LABORATORIES A/S has published its annual report for 2021. The net result was DKK -839,000.
About POLYPEPTIDE LABORATORIES A/S
POLYPEPTIDE LABORATORIES A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named A/S PSE NR. 4948. The management consists of Raoul Bernhardt. The board consists of Juan José Gonzalez Casanova (chair), Christina Ellen Del Vecchio and Raoul Bernhardt. The company is owned by PolyPeptide Laboratories Holding (PPL) AB. The company has 0 employees (2017). In 2025, the company reported a net result of DKK 2,632,000 compared with DKK 7,060,000 the year before. Equity in the 2025 report amounted to DKK 75,499,000.